Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

~8 mi. (Mulhouse, France, +96 more cities)

Hopital Emile Muller

Diffuse Large B-Cell Lymphoma, +1 more condition

brentuximab vedotin, +2 more drugs

chemotherapy, +1 more type

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

~8 mi. (Mulhouse, France, +31 more cities)

Hopital Emile Muller

TNFRSF8 Deficient Expression

Adult T-Cell Leukemia/Lymphoma, +8 more conditions

brentuximab vedotin, +3 more drugs

chemotherapy, +2 more types

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~31 mi. (Basel, Switzerland, +130 more cities)

Universitaetsspital Basel ( Site 1201)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

~31 mi. (Basel, Switzerland, +199 more cities)

Universitaetsspital Basel ( Site 0709)

Hepatocellular Carcinoma

pembrolizumab

immunotherapy

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~31 mi. (Basel, Switzerland, +127 more cities)

Universitätsspital Basel /ID# 215892

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~31 mi. (Basel, Switzerland, +189 more cities)

Universitätsspital Basel /ID# 221261

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~31 mi. (Basel, Switzerland, +228 more cities)

Universitätsspital Basel /ID# 230977

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~31 mi. (Basel, Switzerland, +144 more cities)

Universitatsspital Basel

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

~31 mi. (Basel, Switzerland, +15 more cities)

Universitätsspital Basel

ER Positive

Fallopian Tube Endometrioid Adenocarcinoma, +5 more conditions

letrozole

hormone therapy

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~42 mi. (Freiburg, Germany, +226 more cities)

Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~42 mi. (Freiburg, Germany, +140 more cities)

Universitaetsklinikum Freiburg ( Site 0199)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~42 mi. (Freiburg, Germany, +93 more cities)

Universitaetsklinikum Freiburg ( Site 0512)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types